Scudla V - Search Results

1

Immunoparesis in MGUS - Relationship of uninvolved immunoglobulin pair suppression and polyclonal immunoglobuline levels to MGUS risk categories.

Pika T, Lochman P, Sandecka V, Maisnar V, Minarik J, Tichy M, Zapletalova J, Solcova L, Scudla V, Hajek R. Pika T, et al. Among authors: scudla v. Neoplasma. 2015;62(5):827-32. doi: 10.4149/neo_2015_100. Neoplasma. 2015. PMID: 26278155

2

Analysis of the serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and different stages of multiple myeloma.

Scudla V, Petrova P, Minarik J, Pika T, Bacovsky J. Scudla V, et al. Neoplasma. 2011;58(6):499-506. Neoplasma. 2011. PMID: 21895403

3

The importance of serum levels of selected biological parameters in the diagnosis, staging and prognosis of multiple myeloma.

Scudla V, Pika T, Budikova M, Petrova J, Minarik J, Bacovsky J, Langova K, Zivna J; Czech Myeloma Group. Scudla V, et al. Neoplasma. 2010;57(2):102-10. doi: 10.4149/neo_2010_02_102. Neoplasma. 2010. PMID: 20099972

4

[The role of the assessment of heavy/light chain pairs of immunoglobulin in monoclonal gammopathies].

Ščudla V, Pika T, Minařík J. Ščudla V, et al. Vnitr Lek. 2015 Jan;61(1):60-1, 63-71. Vnitr Lek. 2015. PMID: 25693618 Czech.

5

Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.

Scudla V, Lochman P, Pika T, Minarik J, Zapletalova J, Bacovsky J. Scudla V, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Mar;160(1):84-93. doi: 10.5507/bp.2015.032. Epub 2015 Aug 4. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016. PMID: 26365929 Free article.

6

[Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].

Ščudla V, Lochman P, Pika T, Zapletalová J, Minařík J, Bačovský J. Ščudla V, et al. Cas Lek Cesk. 2015;154(6):292-302. Cas Lek Cesk. 2015. PMID: 26750626 Czech.

7

International Staging System required standardization of biochemical laboratory testing in multiple myeloma.

Tichý M, Maisnar V, Palicka V, Friedecký B, Vávrová J, Novotná H, Cermáková Z, Dastych M, Cechák P, Vogtová D, Jarolímková E, Benáková H, Hachová L, Bezdícková D, Kouril F, Zábranská EA, Zenková J, Slabý P, Scudla V, Gregora E, Spicka I, Straub J, Schützova M, Hájek R. Tichý M, et al. Among authors: scudla v. Neoplasma. 2006;53(6):492-4. Neoplasma. 2006. PMID: 17167717

8

Low-dose thalidomide regimens in therapy of relapsed or refractory multiple myeloma.

Zemanova M, Scudla V, Adam Z, Gregora E, Pour L, Minarik J, Pavlicek P, Pika T, Bacovsky J. Zemanova M, et al. Among authors: scudla v. Neoplasma. 2008;55(4):345-9. Neoplasma. 2008. PMID: 18505347 Clinical Trial.

9

Thalidomide and bortezomib overcome the prognostic significance of proliferative index in multiple myeloma.

Minarik J, Scudla V, Bacovsky J, Zemanova M, Pika T, Ordeltova M, Langova K. Minarik J, et al. Among authors: scudla v. Neoplasma. 2010;57(1):8-14. doi: 10.4149/neo_2010_01_008. Neoplasma. 2010. PMID: 19895166

10

[Assessment of Heavy/ Light Chain Pairs of Immunoglobulin (Hevylite assay) - Benefit for Stratification of Multiple Myeloma?].

Ščudla V, Lochaman P, Pika T, Zapletalová J, Minařík J, Bačovský J. Ščudla V, et al. Klin Onkol. 2015;28(5):359-69. Klin Onkol. 2015. PMID: 26480864 Czech.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters